These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 5538052

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Preliminary results of the treatment with L-Dopa of 30 patients with Parkinsonism].
    Dumas R, Rahme M, Schott B.
    J Med Lyon; 1971 Apr 20; 52(207):599-615. PubMed ID: 5136571
    [No Abstract] [Full Text] [Related]

  • 4. L-dopa and parkinsonism.
    Okihiro MM.
    Hawaii Med J; 1971 Apr 20; 30(5):390-2. PubMed ID: 5160226
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A hort-term evaluation of L-dopa therapy in 34 patients with parkinsonism.
    Mones RJ, Elizan TS.
    J Mt Sinai Hosp N Y; 1969 Apr 20; 36(6):503-15. PubMed ID: 5261089
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment of Parkinsonism with L-dopa--with special reference to clinical effects, side effects and urinary metabolites of catecholamines].
    Uono M, Tanabe H, Yano Y, Nakao K.
    No To Shinkei; 1970 Sep 20; 22(9):1091-101. PubMed ID: 5536082
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effects of L-dopa and stereotaxic surgery in Parkinsonism].
    Sugita K, Mutsuga N, Takaoka Y, Takeda A.
    No To Shinkei; 1970 Sep 20; 22(9):1103-8. PubMed ID: 4918927
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism].
    Sato G, Ito H, Handa Y, Takahashi I, Iijima K.
    No To Shinkei; 1971 Mar 20; 23(3):325-32. PubMed ID: 5107821
    [No Abstract] [Full Text] [Related]

  • 14. [Evaluation of L-DOPA in Parkinsonism with special reference to the study by double-blind method].
    Okajima T, Kubota A, Nakahara N, Takeda S, Shimomura K.
    Naika; 1972 Mar 20; 29(2):335-43. PubMed ID: 4552443
    [No Abstract] [Full Text] [Related]

  • 15. [Long-term treatment of Parkinsonism with L-dopa].
    Presthus J, Holmsen R.
    Tidsskr Nor Laegeforen; 1972 Nov 30; 92(33):2262-6. PubMed ID: 4630916
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. L-dopa in the treatment of Parkinsonism.
    Brezný I, Buranová D, Cernácek J, Trávniková M.
    Act Nerv Super (Praha); 1972 Nov 30; 14(2):96. PubMed ID: 5040182
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of parkinsonism with L-dopa].
    Court J, Kase JC, Palacios E, Mena I.
    Rev Med Chil; 1971 Jun 30; 99(6):399-401. PubMed ID: 5561157
    [No Abstract] [Full Text] [Related]

  • 19. [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].
    Stammler A, Vielhaber K.
    Fortschr Neurol Psychiatr Grenzgeb; 1972 Oct 30; 40(10):564-8. PubMed ID: 4565521
    [No Abstract] [Full Text] [Related]

  • 20. [Advances in L-DOPA therapy for parkinsonism through combination with a decarboxylase inhibitor. Results of a long-term study].
    Wälzholz U, Schönfelder H.
    Nervenarzt; 1972 Oct 30; 43(10):531-2. PubMed ID: 4628192
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.